Listed

Creative Medical Technology Holdings, Inc.: Form 10-K for the period ended Dec 31, 2016

Filed with the SEC on Feb 13, 2017 and accepted by EDGAR at Feb 13, 2017, 15:58 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2016-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue12 months2016-01-01 to 2016-12-31$0us-gaap:Revenues
Research and development12 months2016-01-01 to 2016-12-31$85.3kus-gaap:ResearchAndDevelopmentExpense
Operating income12 months2016-01-01 to 2016-12-31−$766.1kus-gaap:OperatingIncomeLoss
Income tax12 months2016-01-01 to 2016-12-31$0us-gaap:IncomeTaxExpenseBenefit
Net income12 months2016-01-01 to 2016-12-31−$766.1kus-gaap:NetIncomeLoss
Diluted EPS12 months2016-01-01 to 2016-12-31−$0.01us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow12 months2016-01-01 to 2016-12-31$445.2kus-gaap:NetCashProvidedByUsedInOperatingActivities
Cash and equivalentsAt period end2016-12-31$221.9kus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2016-12-31$221.9kus-gaap:AssetsCurrent
Total assetsAt period end2016-12-31$322.5kus-gaap:Assets
Current liabilitiesAt period end2016-12-31$453.9kus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2016-12-31$480.3kus-gaap:Liabilities
Shareholders' equityAt period end2016-12-31−$157.8kus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001144204-17-007873. Last ingested by Listed: Nov 14, 2026, 19:08 ET. Listed shows no prices and gives no investment advice.